Ingredient name record
BAKUCHIOL
Evidence at a glance
Evidence coverage, not an efficacy or safety score.
Identity & coverage details
Official CosIng inventory context recorded; chemical identity and the complete current regulatory profile remain unverified; selected human studies available.
Recorded presence is not a safety rating, recommended dose or benefit claim.
Identity and formulation context
Names are indexed using case and whitespace normalization. Botanical, chemical and marketing identities have not been independently equated.
Bakuchiol is not retinol or a retinoid. Equal percentages with different application frequencies do not establish equivalent delivered doses or equivalent outcomes for other vehicles.
Functions listed by CosIng
Inventory functions describe the ingredient entry, not a finished product’s effects.
How this inventory match is used
The European Commission’s CosIng inventory is informational. An entry is not permission to use an ingredient or a safety assessment. Listed functions describe the inventory entry; they do not establish a finished product’s effects. The match uses the exact ingredient name, with case and whitespace normalization.
BAKUCHIOL · Inventory identifiers
- Inventory record
- 32053 · Active
- CAS identifiers in this entry
- 10309-37-2
- EC identifiers in this entry
- Not listed
Checked 2026-10-02 · Read the official CosIng entry
Human study context
Primary publications checked 2026-10-03. These are selected studies, not a systematic review, safety rating or instructions for using a product.
Prospective, randomized, double-blind assessment of topical bakuchiol and retinol for facial photoageing.
- Material tested
- 0.5% bakuchiol cream versus 0.5% retinol cream.
- Study design
- Randomized, double-blind active-comparator trial.
- Participants
- 44 patients with facial photoageing.
- Concentration and schedule in the study
- 12 weeks; bakuchiol twice daily, retinol once daily.
- What the authors reported
- Both groups improved measured wrinkle area and pigmentation; no statistically significant between-group difference. Retinol users reported more scaling and stinging.
What this does not establish
- Small trial without a vehicle-only group; no detected difference does not prove equivalence.
- Different application frequencies confound dose comparisons. Journal issue 2019; first electronic publication 2018.
Still unverified
- Selected primary abstracts only, not a systematic review or a complete scientific profile.
- Test preparations have not been matched to any Treatfolio product, market, batch or package.
- Study schedules are not consumer instructions; regulatory status and personal suitability require separate evidence.
- Chemical identity, the complete current regulatory profile and finished-product effects remain unverified.
Search interest & consumer questions
Explore dated interest, supplier activity and selected discussions. Topic labels do not establish ingredient equivalence or product effects.
Products with recorded occurrences
22 product records. Matches include reviewed amount annotations where available. Open a product to see the original source token, market and date.
Related product examples are shown above. Search all recorded products.